Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06842693 · ClinicalTrials.gov registry record · NA

Testing Non-nutritive Sweetener Labels in Chile

A NA study of Diet, Healthy, sponsored by University of North Carolina, Chapel Hill.

Completed
Registry status
NA
Development phase
3,916
Enrollment target
1
Study location

NCT06842693: Completed NA study of Diet, Healthy, sponsored by University of North Carolina, Chapel Hill.

NCT06842693 is a NA study of Diet, Healthy that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 3,916 participants, above the 426-participant average among 48 other Diet, Healthy trials with a reported enrollment target (819% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06842693, a NA study of Diet, Healthy, has completed, sponsored by University of North Carolina, Chapel Hill.

COMPLETED
Registry status
NA
Development phase
3,916 participants
Enrollment target
1
Study location

Study Summary

The goal of this experiment is to examine the effects of 2 types of non-nutritive sweetener (NNS) warning labels among a sample of Chilean parents. The main questions this experiment aims to answer are: Do non-nutritive sweetener warning labels improve consumers' ability to identify when a product contains non-nutritive sweeteners? Do non-nutritive sweetener warning labels impact on consumers' selection of non-nutritive sweetener-sweetened, unsweetened, and/or sugar-sweetened products for their children? Participants will be randomly assigned to 1 of 3 types of labels and view their assigned label on 3 sets of products. Each set will display 4 similar products: one unsweetened, one sweetened with sugar, one sweetened with non-nutritive sweeteners, and one sweetened with both sugar and non-nutritive sweeteners. For each set, participants will identify which product(s) contain NNS and select the product that they would purchase for their child. Researchers will compare results across label types.

Primary Outcome

Correct identification of products that contain non-nutritive sweeteners will be measured by survey. Response will be coded in a dichotomous 0-1 range, where 1 indicates that the participant correctly identified the products that contained non-nutritive sweeteners and 0 indicates that the participant did not correctly identify the products that contained non-nutritive sweeteners.

Conditions Studied

Interventions

  • BEHAVIORAL Control
  • BEHAVIORAL Chilean non-nutritive sweetener label
  • BEHAVIORAL Colombian non-nutritive sweetener label

Study Locations (1)

North Carolina

  • The University of North Carolina at Chapel Hill's Gillings School of Global Public Health - Chapel Hill

Trial Details

FieldValue
Enrollment Target 3,916 participants
Start Date 2025-07-14
Est. Completion 2025-08-31
Phase NA

What the finished NCT06842693 record still lists

NCT06842693 is an interventional study that assigns participants to a tested intervention. Its 3,916 participants enrollment target places it among the larger protocols in the corpus, above the 426-participant average among 48 other Diet, Healthy trials with a reported enrollment target (819% higher).

The record links to 1 condition, with Diet, Healthy appearing as the primary indexed condition, and to 3 interventions - of which Control is the first listed.

NCT06842693 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT06842693 about?

NCT06842693 is a clinical study titled "Testing Non-nutritive Sweetener Labels in Chile". The goal of this experiment is to examine the effects of 2 types of non-nutritive sweetener (NNS) warning labels among a sample of Chilean parents. The main questions this experiment aims to answer are: Do non-nutritive sweetener warning labels improve consumers' ability to identify when a product ...

What is the current status of trial NCT06842693?

This trial is currently completed. It is a NA study. The enrollment target is 3,916 participants. The study started on 2025-07-14. Estimated completion is 2025-08-31.

What conditions does trial NCT06842693 study?

This clinical trial studies the following conditions: Diet, Healthy.

What interventions are being tested in trial NCT06842693?

The interventions under investigation include: Control (BEHAVIORAL), Chilean non-nutritive sweetener label (BEHAVIORAL), Colombian non-nutritive sweetener label (BEHAVIORAL).

Who is sponsoring clinical trial NCT06842693?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06842693 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diet, Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06842693's enrollment target sits among peer trials

3,916 2nd of 48 the highest of 48 other Diet, Healthy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Diet, Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05919342 · 3,904 participants · NA

    Screening for earlY Heart Failure Diagnosis and Management in Primary Care or at HOme Using Natriuretic Peptides and echocardiographY "SYMPHONY-HF"

  • NCT03936335 · 3,930 participants

    An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis (AD)

  • NCT05879926 · 3,960 participants · Phase 3

    Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

  • NCT07087613 · 3,850 participants

    Deep Learning Detection of Pulmonary Hypertension and Low Ejection Fraction Via Digital Stethoscope and 3-Lead ECG

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06842693, the US trial registry maintained by the National Library of Medicine. NCT06842693 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.